BEIJING, Feb 28 (Global Times): China's first Ad5-nCoV Covid-19 vaccine was rolled out on Friday (Feb 26). One of the developers of the single-dose vaccine said that the annual production capacity can reach 500 million doses, which means 500 million people can be vaccinated in a year.
Phase-I clinical trials of the vaccine started on March 16, 2020, making it the world's first Covid-19 candidate vaccine that entered clinical trials.
Already a subscriber? Log in.
Celebrate Merdeka with 50% Off!
T&C applies.
![](https://cdn.thestar.com.my/Themes/img/sub_paywall_TSM.webp)
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!